Viewing Study NCT04913220


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2025-12-26 @ 3:13 AM
Study NCT ID: NCT04913220
Status: TERMINATED
Last Update Posted: 2025-03-05
First Post: 2021-05-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-15
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-22
Primary Completion Date Type: ACTUAL
Completion Date: 2025-02-18
Completion Date Type: ACTUAL
First Submit Date: 2021-05-28
First Submit QC Date: None
Study First Post Date: 2021-06-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-02-21
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-03-03
Last Update Post Date: 2025-03-05
Last Update Post Date Type: ACTUAL